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Adolescents and adults with autism spectrum disorder (ASD) are at elevated risk of co-occurring mental health prob-
lems. These are often undiagnosed, can cause significant impairment, and place a very high burden on family and
carers. Detecting co-occurring disorders is extremely important. However, there is no validated screening tool for this
purpose. The aim of this pilot study is to test the utility of the strengths and difficulties questionnaire (SDQ) to screen
for co-occurring emotional disorders and hyperactivity in adolescents and adults with ASD. The SDQ was completed
by 126 parents and 98 individuals with ASD (in 79 cases both parent and self-report were available from the same
families). Inter-rater reliability, test-retest stability, internal consistency, and construct validity were examined. SDQ
subscales were also compared to clinically utilized measures of emotional disorders and hyperactivity to establish the
ability to predict risk of disorder. Inter-rater reliability (r50.42), test-retest stability (r50.64), internal consistency
(a50.52–0.81) and construct validity (r50.42–0.57) for the SDQ subscales were comparable to general population
samples. Parent- and self-report SDQ subscales were significantly associated with measures of anxiety, depression and
hyperactivity (62–74% correctly classified). Parent-report performed significantly better than self-report; adults with
ASD under-reported difficulties. The SDQ shows promise as a simple and efficient way to screen for emotional disor-
ders and hyperactivity in adolescents and adults with ASD that could help reduce the impact of these disorders on
individuals and their families. However, further more systematic attempts at validation are warranted. Autism Res
2016, 9: 1353–1363. VC 2016 International Society for Autism Research, Wiley Periodicals, Inc.
Keywords: autism spectrum disorder; co-occurring disorder; co-morbid disorder; hyperactivity; attention deficit hyper-
activity disorder; anxiety; depression; obsessive–compulsive disorder
Introduction
Autism spectrum disorder (ASD) is a highly heritable
neurodevelopmental disorder characterized by impair-
ment in social communication and repetitive, stereo-
typed behaviors [World Health Organization, 1993].
ASD is usually a life-long disorder with prevalence rates
among adults estimated at 1 in 100 [Brugha et al.,
2011]. Rates of psychiatric comorbidity are particularly
high among individuals with ASD. The most prevalent
comorbidities are mood disorders, anxiety disorders,
attention-deficit hyperactivity disorder (ADHD) and
obsessive–compulsive disorder (OCD), with prevalence
rates of approximately 53, 50, 43, and 24%, respectively
[Buck et al., 2014; Hofvander et al., 2009; Vannucchi
et al., 2014]. Psychiatric comorbidity in ASD causes sig-
nificant functional impairment to the individual, result-
ing in greater contact with services [Leyfer et al., 2006],
and a level of burden comparable to that reported by
caregivers of persons with acquired brain injury
[Cadman et al., 2012]. Co-occurring conditions in ASD
are potentially treatable [Russell et al., 2013] and recog-
nizing them should be a priority for community and
specialist ASD services. However, comorbidity often
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goes unrecognized in ASD, with less than half of those
with co-occurring conditions receiving a community-
based psychiatric diagnosis [Buck et al., 2014; Hayward
et al., Service use and needs among those with an ASD
in adolescence and young adulthood: Unrecognised
psychiatric conditions, unpublished manuscript]. To
assist in identification of psychiatric comorbidity, clini-
cians need valid and reliable screening tools. However,
there are currently no screening tools that screen for a
range of psychiatric comorbidity validated for use in
adults with ASD. The aim of this pilot study was to
establish whether a modified version of the Strengths
and Difficulties Questionnaire (SDQ) – one of the most
widely used screening tools for psychopathology in
children and adolescents in the United Kingdom –
could fulfill this purpose.
The SDQ is a brief, 25-item questionnaire with five
subscales: emotional problems, conduct problems, hyper-
activity–inattention, peer problems, and prosocial behav-
ior. It has excellent psychometric properties – mean
Cronbach alpha50.73 [Goodman, 2001] and mean test-
retest reliability50.81 [Muris, Meesters, & van den Berg,
2003] – and can be administered as self- or informant-
report [Goodman, 2001]. The SDQ has the potential to
be a good instrument for use in adolescents and adults
with ASD because it: (a) can be used to screen for psy-
chopathologies that are commonly associated with ASD
(anxiety, depression, and ADHD); (b) is relatively brief;
(c) is likely that cooperation is better when using a single
questionnaire rather than several separate questionnaires
(for anxiety, depression, ADHD, etc.); and (d) can be
administered to individuals with ASD and their parents
(or other informants). We investigated the SDQ in ado-
lescents and adults with ASD, testing inter-rater reliabil-
ity, test-retest stability, internal validity, and external
validity (against clinically utilized measures of anxiety,
depression, and ADHD). We hypothesized that: (1) the
SDQ would demonstrate inter-rater reliability, test-retest
stability, internal consistency, and construct validity that
is comparable to values from non-ASD populations; (2)
the SDQ emotional problems subscale would be signifi-
cantly correlated with multiple other measures of anxi-
ety disorders and depression, and both self- and
informant-report would show good sensitivity and speci-
ficity in relation to clinical risk of emotional disorders;
and (3) the SDQ hyperactivity subscale would be signifi-
cantly correlated with multiple measures of ADHD, and
both self- and informant-report would show good sensi-
tivity and specificity in relation to clinical risk of ADHD.
Method
Sample
Individuals with a clinical diagnosis of ASD and their
parents were recruited from Child and Adolescent
Mental Health Services, adult clinics, charities, and
clinical research databases. One-hundred and forty-five
families participated: from these families, 98 individuals
with ASD (age 14–59 years) and 126 parents (mostly
mothers) provided data; in 79 families both self- and
parent-report data were available (see supporting infor-
mation Tables S1 and S2 for details). Of participating
families, 71.0% of patients were currently in or had
recently sought help from clinical services because of
ASD-related difficulties. Diagnosis of ASD was con-
firmed using the autism diagnostic interview-revised
(ADI-R) [Lord, Rutter, M., & Le Couteur, 1994] or the
autism diagnostic observation schedule-generic (ADOS-
G) [Lord et al., 2000]. The study was approved by The
Joint South London and Maudsley and The Institute of
Psychiatry NHS Research Ethics Committee.
Measures
Strengths and Difficulties Questionnaire
The SDQ is a brief, 25-item questionnaire that can be
administered as self-report, or to parents and teachers
of children and adolescents [youthinmind, 2012]. It has
been adapted for use in adults with minor alteration of
some items (e.g., “I often offer to help others (family
members, friends, colleagues)” instead of “I often vol-
unteer to help others (parents, teachers, children)”
[youthinmind, 2013]. It covers common areas of emo-
tional and behavioral difficulties, with five subscales –
emotional problems, conduct problems, hyperactivity,
peer problems, and prosocial behavior – and an impact
supplement, which enquires about chronicity, distress,
social impairment, and burden to others. Scores for sub-
scales are classified as “normal,” “borderline,” or
“abnormal” according to published cut-offs [Goodman,
1997]. A three factor model is produced by summing
scores on the emotional and peer problems subscales
(internalizing) and hyperactive and conduct problems
subscales (externalizing).
Previously validated algorithms [Goodman et al.,
2004] were used to predict psychiatric disorder by bring-
ing together information on symptoms and impact from
self- and parent-report SDQ for ADHD/hyperkinetic dis-
orders and anxiety–depressive disorders. Each is pre-
dicted to be “unlikely,” “possible,” or “probable.”
“Probable” hyperactivity–inattention disorder requires
evidence of pervasiveness through parent and teacher
ratings; because teacher ratings were not available, only
“unlikely” or “possible” predictions were produced.
Psychiatric Diagnosis
Psychiatric comorbidity was measured using the devel-
opment and wellbeing assessment (DAWBA)
[Goodman, Ford, Richards, Gatward, & Meltzer, 2000]
and clinical notes where available (n572). The DAWBA
is a computer-based psychiatric interview that can be
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completed by youths/adults and their parents. The
DAWBA was originally developed for children and ado-
lescents but has been adapted for use in adults by modi-
fying the language to make the content appropriate to
adults (see youthinmind [2015] for sample interviews).
Around 95% of the content remains the same as the
original version and the while formal validation studies
of the adult version have yet to be published, the
DAWBA is increasingly used in longitudinal studies of
adults and trained clinical raters have reported that the
rating process is very similar to the adolescent version
[Robert Goodman, personal communication, November
9, 2015]. The DAWBA can be administered by interview
or can be completed online by patients and their parents.
The online version has been shown to produce broadly
similar prevalence estimates for disorders as those pro-
duced using interview techniques, in both a general pop-
ulation sample and a sample affected by neurological
disorder [Goodman, 2013] and agreement with clinical
diagnosis of specific disorders has been shown to range
between 74 and 99% in an outpatient sample [Aebi
et al., 2012]. The DAWBA uses closed and open-ended
questions that cover the operationalized diagnostic crite-
ria of the DSM-IV, DSM-5 and ICD-10 [American Psychi-
atric Association, 2000]. Screening questions and the
SDQ are used to shorten sections of the interview when
it is unlikely that the person has difficulties in that area.
In instances where the answers to the screening ques-
tions do not indicate the presence of disorder, but the
SDQ scores do, the section is entered. If the answers to
the screening questions do indicate the presence of disor-
der, the SDQ scores are not considered. An algorithm
uses responses from self-report and informants to gener-
ate probability bands for the presence of particular psy-
chiatric disorders. SDQ scores do not contribute to the
DAWBA probability bands. Clinical raters then review all
information and assign a diagnosis for each disorder. In
this study, two trained clinical raters assigned diagnoses
and final DAWBA diagnosis for each disorder was
decided through consensus between the two raters.
Where available, clinical notes were reviewed and
comorbid psychiatric disorders were coded as “no,”
“possible” (e.g., suspected but the individual had not
been further assessed), or “definite.”
Dichotomous variables indicating high risk of particu-
lar disorders were also created: high risk was indicated
by either a DAWBA diagnosis by a clinical rater or a
definite diagnosis recorded in their clinical notes.
In addition to the DAWBA, we assessed the external
validity of the SDQ against screening questionnaires
that are frequently used in clinical settings.
Screening Questionnaires
Symptoms of ADHD were measured using the Barkley
Adult ADHD Rating Scale-IV (BAARS-IV) [Barkley &
Murphy, 2006]. The BAARS-IV is a commonly used,
validated 18 item rating scale of DSM-IV criteria for
ADHD that has been used in adult ASD populations
[Johnston et al., 2013; Wilson et al., 2013]. Parent- and
self-report versions were used.
Anxiety and depression were measured using the hos-
pital anxiety and depression scale (HADS) [Zigmond &
Snaith, 1983]. The HADS is a commonly used, 14-item
self-report screening tool for anxiety and depression. It
has demonstrated excellent psychometric properties
and is used routinely in clinical and research contexts,
including in adult ASD populations [Abell & Hare,
2005; Hare, Wood, Wastell, & Skirrow, 2015; Kanai
et al., 2011; Luke, Clare, Ring, Redley, & Watson,
2011].
The obsessive–compulsive inventory-revised (OCI-R)
[Foa et al., 2002] was used to measure symptoms of
obsessive–compulsive disorder (OCD). The OCI-R is an
18-item self-report measure with excellent psychometric
properties [Foa et al., 2002] that performs well in adults
with ASD [Cadman et al., 2015].
Procedure
Following informed consent, login details for the SDQ
and DAWBA were issued to participants. Each individ-
ual had log in details specific to them to enable adoles-
cents/adults and parents to separately log in and
complete them. The SDQ was completed as part of the
DAWBA package, online (92% of adolescents/adults,
91% of parents) or by telephone or face-to-face inter-
view (8% of adolescents/adults, 9% of parents); in all
cases the SDQ was completed before the DAWBA. Paper
versions of the BAARS-IV, HADS, and OCI-R were
posted to participants to complete and return using a
pre-paid envelope. If participants consented to their
medical records being reviewed then relevant records
were requested from their current mental health
service.
Statistical Analysis
Data were analyzed using SPSS for Windows (version
20.0) [IBMCorp., 2011] and Mplus (version 7.3)
[Muthen & Muthen, 1998].
The SDQ was validated against other indicators of
high risk of disorder by examining the correlation
(Spearman’s q) between SDQ subscale scores and other
measures of psychiatric disorder, namely: DAWBA prob-
ability bands, clinical diagnosis (no, possible, or definite
diagnosis), and standard screening questionnaires. To
ensure that associations were not driven by the severity
of overall problems (e.g., individuals with more severe
problems being rated non-specifically across all SDQ
subscales) correlations were repeated controlling for
SDQ impact scores (partial q). Additionally, correlations
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with the three-category ordinal clinical diagnosis varia-
bles were repeated as polyserial correlations.
The second step was to establish whether the SDQ
bands – normal, borderline, abnormal – predict high
risk of disorder, using parent-report SDQ, self-report
SDQ, and predictive algorithm based on combined par-
ent- and self-report SDQ. SDQ emotional problems and
hyperactivity subscales were compared to high risk of
disorder (indexed by having a DAWBA clinical rater
assigned diagnosis and/or a definite diagnosis recorded
in their clinical notes). For parent- and self-report SDQ,
borderline and abnormal bands were collapsed into one
category. When the predictive algorithm was used, pos-
sible and probable categories were collapsed for emo-
tional disorders (probable category not available for
hyperactivity; see Measures: SDQ, above). Sensitivity,
specificity, positive predictive value (PPV), and negative
predictive value (NPV) were calculated for each rater
and the predictive algorithm, as well as the percentage
of individuals correctly classified and the odds ratio. To
establish whether parent- or self-report SDQ was signifi-
cantly better at identifying cases, the proportion of true
positives and negatives was compared between parent-
and self-report SDQ using the Z test.
Construct validity was tested using multitrait–multi-
method (MTMM) [Campbell & Fiske, 1959; Goodman,
Lamping, & Ploubidis, 2010] analysis. MTMM is based
on producing a correlation matrix of multiple traits
(e.g., the subscales of the SDQ) measured by multiple
methods (e.g., parent- and self-report). Construct valid-
ity is assessed through comparisons across raters and
across subscales. For example, the correlation between
parent- and self-report emotional subscale scores (a con-
vergent correlation coefficient) would be expected to be
higher than between parent-report emotional and self-
report hyperactivity subscales (a discriminant correla-
tion coefficient). Where there is no difference between
convergent and discriminant correlations, it is inferred
that these subscales may not be tapping into the same
constructs across raters. MTMM correlations were
performed using Spearman’s q and compared using
Steiger’s Z tests. We also present Cronbach’s alpha, a
coefficient of internal consistency, for each subscale in
each rater.
Results
Description of Sample
SDQ and DAWBA data were available from 126 parents
(offspring gender, 81% male; offspring age, mean
[SD]523.5 [10.8] years) and 98 adolescents/adults with
ASD (75% male; age, mean [SD]527.4 [12.3] years); of
these, there were 79 dyads with both parent- and self-
report data. Of these dyads, subsets of cases had clinical
notes relating to co-occurring disorders (n539) or ques-
tionnaire data (n528). See supporting information
Tables S1 and S2 for more detail.
All participants had a previous clinical diagnosis of
an autism spectrum disorder. Participants met ADI-R
autism genetic resource exchange criteria for “autism,”
“not quite autism” or “broad spectrum” [AGRE, 2015].
In all but five cases classified as “broad spectrum,” this
resulted from missing data for domain D; they other-
wise met criteria for “autism” or “not quite autism”
across the three symptom domains. Two participants
classified as “broad spectrum” additionally had ADOS
data and met criteria for autism. Reviewing clinical
notes and diagnoses made by DAWBA clinical rater,
46.5% of participants were at high risk of co-morbid
ADHD and 59.9% were at high risk of a co-morbid emo-
tional disorder. Formal IQ data were not available but
8% of the sample was diagnosed with intellectual dis-
ability (also known as learning disability in UK health
services).
Inter-rater Reliability
Pearson’s correlation between parent- and self-report
total SDQ scores was r50.42, P<0.05. This is compara-
ble to the value previously reported in a large scale epi-
demiological sample (r50.48) [Goodman, 2001].
Test-Retest Stability
The SDQ was re-administered to parents (n569) and
adolescents/adults (n535) with ASD after an average
interval of 11.8 months (SD52.75; range, 6–12). The
mean retest stability was r50.64 and did not differ by
informant (parent-report: r50.62; self-report: r50.66;
see Table 1).
External Validity Against High Risk of Disorder
Parent- and self-report SDQ emotional problems and
hyperactivity subscales (normal vs. borderline/abnormal
bands) and multi-rater predictive algorithm (unlikely
vs. possible/probable bands) were compared to high risk
Table 1. Test-Retest Stability: Reliability Coefficients for
SDQ Scores
Time 1 3 Time 2 correlations
Parent-report Self-report
SDQ scale (n5 69) (n5 35)
Emotional problems 0.55 0.64
Behavioral Problems 0.70 0.64
Hyperactivity 0.70 0.55
Peer problems 0.58 0.72
Prosocial behavior 0.62 0.69
Impact 0.60 0.61
Total difficulties 0.59 0.74
All Spearman’s correlation coefficients significant at P< 0.01.
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of emotional disorder or ADHD, defined as having a
DAWBA clinical rater diagnosis and/or diagnosis
recorded in clinical notes.
Emotional Disorder
Figure 1 shows ratings for SDQ emotional problems or
disorder in those at high and low risk of clinical diag-
nosis of any emotional disorder. For both parent- and
self-report emotional problems, more than half of those
rated as borderline or abnormal were at high risk of
emotional disorder and the majority of those rated as
normal were at low risk of emotional disorder. Parents
were more likely to give abnormal ratings, resulting in
more true and false positives, and self-report was more
likely to result in normal ratings, resulting in more true
and false negatives.
Table 2 shows the sensitivity, specificity, positive pre-
dictive value (PPV), and negative predictive value (NPV)
of SDQ emotional problems subscale in predicting high
risk of emotional disorders. Parent-reported SDQ emo-
tional problems had high sensitivity (90% of cases
detected) whereas only around half (55%) of cases were
detected using self-ratings. The PPV showed that 60–
70% of cases identified were true positives and 30–40%
were false positives. The NPV showed that 60–75% of
normal ratings reflected low risk of disorder, whereas
25–40% represented missed cases. The odds of clinical
disorder were significantly elevated in those identified
using the SDQ, using parent- or self-ratings. Multi-rater
predictive algorithm performed similarly to parent-
report SDQ, with only slightly improved ability to cor-
rectly identify risk of clinical disorder. Restricting analy-
ses to those who were currently in or had recently
sought help from clinical services for ASD-related diffi-
culties further reduced performance of self-report SDQ
emotional problems; it did not perform significantly
above chance level (see supporting information Table
S3).
There was no significant difference in the PPV
between parent- and self-rated SDQ emotional problems
(Z score521.03, P50.303); for NPV, parent-report was
significantly better than self-report (Z score522.11,
P50.034).
Hyperactivity
A similar pattern was observed for SDQ hyperactivity.
Figure 1 and Table 2 show that the majority (60–65%)
of those with borderline or abnormal ratings were at
high risk of ADHD and the majority (67–84%) of those
with normal ratings were at low risk. Odds ratios were
significant for parent-ratings, self-ratings, and multi-
rater predictive algorithm. Parent-ratings detected more
cases (86%) than self-ratings (60%). In two cases, ele-
vated SDQ scores, rather than DAWBA screening ques-
tions, had resulted in participants completing the
DAWBA hyperactivity module; excluding these two
cases did not change estimates of sensitivity, specificity,
PPV or NPV. Restricting analyses to those who were in
or had recently sought help from clinical services
resulted in an increase in sensitivity for both parent-
and self-report, though a decrease in specificity for self-
report (see supporting information Table S3).
There was no significant difference in the PPV
between parent- and self-rated SDQ hyperactivity (Z
score50.64, P50.522); for NPV, parent-report was sig-
nificantly better than self-report (Z score52.45,
P50.014).
Specificity of SDQ Subscales
Spearman’s rank correlations (q) and, where appropri-
ate, polyserial correlations between SDQ subscales and
other measures of comorbid disorders (DAWBA
Figure 1. Number of individuals at high or low risk of clinical diagnosis of any type of emotional disorder (for SDQ emotional prob-
lems) or ADHD/hyperkinesis (for SDQ hyperactivity) in each SDQ band (parent-report, self-report, and multi-informant predictive
algorithm). NB Probable band for multi-rater predictive algorithm for hyperactivity requires evidence of pervasiveness across settings
from parent and teacher SDQ, which was not available in this sample.
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probability bands, clinical diagnosis, and standard
screening questionnaires) were examined (see support-
ing information Tables S4 and S5). Parent-report SDQ
scores showed the expected pattern of associations for
emotional problems, correlating significantly with
measures of anxiety disorders (q50.48–0.74), OCD
(q50.32–0.58) and depression (q50.58 for DAWBA
probability bands; other measures of depression were
not significant) and hyperactivity, which correlated sig-
nificantly with measures of ADHD (q50.49–0.77; corre-
lations with self-report BAARS-IV was not significant).
This was true even when the effect of SDQ impact
scores were controlled (using partial correlations), sug-
gesting that these associations were not being driven by
severity of problems regardless of domain. SDQ parent-
reported peer problems also showed some association
with anxiety disorders and hyperactivity, though only
the latter was still significant after controlling for
impact scores. Self-report SDQ showed similar correla-
tions between SDQ emotional problems and measures
of anxiety disorders, OCD and depression, and between
SDQ hyperactivity and measures of ADHD (supporting
information Table S5). However, self-report appeared to
be less specific than parent-report: hyperactivity and
peer problems subscales both correlated significantly
with anxiety disorders and OCD, even after controlling
for impact scores.
Construct Validity of the SDQ Subscales
Table 3 presents MTMM analysis of the SDQ subscales.
Cronbach alpha coefficients ranged between 0.52 and
0.81. The cross-method correlations of the same traits
are presented in bold; all were significantly different
from zero (P < 0.001) and in the moderate range (0.42–
0.57).
In the majority of cases, the convergent correlations
were significantly larger than the other correlation coef-
ficients in the same row or column (the discriminant
correlations), were of moderate size, and were larger
than those previously reported in an epidemiological
sample of adolescents [Goodman et al., 2010]. The
exceptions to this were: (a) the peer problems subscale,
where both parent- and self-rated SDQ showed some
evidence of poor discriminant validity relative to emo-
tional problems reported by the other rater; (b) the
parent-reported behavioral problems subscale, which
demonstrated poor discriminant validity relative to self-
reported emotional problems; and (c) self-reported
behavioral problems, which demonstrated poor discrim-
inant validity relative to parent-reported hyperactivity.
However, the statistical power achieved was low
(34–40%) for these discriminant correlations. The three
factor (internalizing–externalizing–prosocial) contrast
provided much better convergent and discriminant
validity (see Table 4).
Discussion
Rates of psychiatric comorbidity are extremely high in
adolescents and adults with ASD, causing significant
impairment to affected individuals and great burden to
their families. Regular screening for common comorbid
disorders, such as anxiety, depression, and ADHD, is
extremely important, yet there are no screening tools
that have been validated in this population. We identi-
fied the SDQ as a tool that could potentially be used for
this purpose and carried out a pilot study to test its reli-
ability and validity in a sample of adolescents and
adults with ASD who were either currently in or had
recently sought help from clinical services for ASD-
related difficulties. Our findings suggest that the SDQ
shows some promise in this population; however, more
systematic attempts at validation are warranted.
We assessed the reliability of the SDQ by examining
inter-rater agreement, internal consistency, and test-
retest stability. Inter-rater agreement between parent-
and self-report was comparable to the agreement
Table 2. Classification Statistics for SDQ Emotional Problems and Hyperactivity Subscales
SDQ subscale Sens Spec PPV NPV % Correctly classified Odds ratio 95% CI
Emotional problems Parent 0.90 0.32 0.59 0.75 62 4.32 1.25–14.95
Self 0.55 0.70 0.67 0.59 62 2.89 1.13–7.40
Emotional disorder Multi-rater 0.90 0.41 0.62 0.79 66 6.14 1.81–20.87
Hyperactivity Parent 0.86 0.62 0.65 0.84 73 9.75 3.14–30.28
Self 0.60 0.67 0.60 0.67 64 3.00 1.18–7.62
Hyperactivity disorder Multi-rater 0.86 0.64 0.67 0.84 74 10.80 3.46–33.70
SDQ emotional problems/disorder tested against high risk of any emotional disorder (generalized anxiety disorder, specific phobia, social phobia,
panic disorder/agoraphobia, obsessive–compulsive disorder, major depression); SDQ hyperactivity/hyperactivity disorder tested against high risk of
any ADHD/hyperkinesis disorder; high risk of disorder was defined as having DAWBA clinical rater diagnosis and/or definite diagnosis recorded in
clinical notes. SDQ borderline/abnormal and possible/probable ratings were collapsed and contrasted to normal or unlikely ratings. Sens: sensitivity,
Spec: specificity, PPV: positive predictive value, NPV: negative predictive value. n5 77. Power achieved for: emotional problems parent-report
SDQ5 99%; self-report SDQ5 49%; multi-rater algorithm5 99%; hyperactivity parent-report SDQ5 95%; self-report SDQ5 50%; multi-rater
algorithm5 97%.
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reported in a non-ASD population using the SDQ
[Goodman, 2001]. Internal consistency was generally
good across all subscales and values for Cronbach’s
alpha were mostly higher than those previously
reported in a non-ASD sample [Goodman, 2001]. Test-
retest stability was also comparable to that reported in
a non-ASD population, despite being carried out after a
longer interval [Goodman, 2001]. Therefore, overall the
SDQ appears to perform as reliably in adolescents and
adults with ASD as it does in non-ASD populations of
children and adolescents.
Having demonstrated good reliability, we next
explored to what extent the parent- and self-report ver-
sions of SDQ showed good external validity when com-
pared to clinically utilized measures of comorbid
disorders. The parent-report SDQ emotional problems
subscale showed reasonable validity, being specifically
associated with measures of emotional disorders (gener-
alized anxiety disorder, specific phobia, social phobia,
panic and agoraphobia, OCD, and depression) and
detecting 90% of individuals at high risk of disorder.
Similarly, the parent-report SDQ hyperactivity subscale
was specifically associated with measures of ADHD and
detected 86% of those at high risk of ADHD. Therefore
obtaining a parent-report SDQ and taking borderline
and abnormal scores on emotional problems or hyper-
activity subscales to indicate risk of disorder would be
an effective way of detecting the majority of those in
need of further assessment and treatment. In practice it
might be possible to use just the emotional and hyper-
activity subscales as a very brief 10-item screening tool
that could be used during routine appointments. How-
ever, the specificity was relatively low and the rate of
false positives was up to 40% and so intensive work up
of SDQ positive cases may not always be warranted; fur-
ther screening with more in depth tools (such as the
DAWBA) in the first instance could provide a more
cost-effective approach.
Table 3. MTMM Analyses for the Five SDQ Subscales
Parent-report SDQ Self-report SDQ
Emo Behav Hyp Peer Pro Emo Behav Hyp Peer Pro
Parent SDQ Emo a5 0.78
Behav 0.36 a5 0.73
Hyp 0.31 0.40 a5 0.77
Peer 0.44 0.34 0.23 a5 0.52
Pro 20.14 20.45 20.16 20.26 a5 0.81
Self-report SDQ Emo 0.57***A 0.43A,1 0.08 0.292 20.06 a5 0.76
Behav 20.06 0.42***B,1 0.32B 20.01 20.07 0.14 a5 0.61
Hyp 0.18 0.15 0.56*** 0.05 20.07 0.35 0.21 a5 0.72
Peer 0.25C 20.06 20.20 0.45***C,2 20.12 0.57 0.16 0.09 a5 0.62
Pro 20.02 20.10 20.02 20.07 0.47*** 20.15 20.23 20.13 20.18 a5 0.73
MTMM5multi-trait multimethod, Emo5 SDQ emotional problems subscale, Behav5 behavioral problems, Hyp5 hyperactivity, Peer5 peer problems,
Pro5 prosocial behavior. n5 126 parents; n 5 98 adolescents/adults with ASD; n 5 79 for parent-self-report comparison. Values are Spearman’s correla-
tion coefficients, except values in the diagonals which are Cronbach’s alphas. Cross-method correlations of same traits are presented in bold.
***P< 0.001.
Coefficients in the same row (A,B,C) or the same column (1,2) with the same superscript do not differ from each other using Steiger’s Z tests
(AP5 0.173; BP5 0.375; CP5 0.068, 1P5 0.936; 2P5 0.095).
Table 4. MTMM Analyses for the Internalizing, Externalizing, and Prosocial SDQ Subscales
Parent-report SDQ Self-report SDQ
Int Ext Pro Int Ext Pro
Parent-report
SDQ
Int a5 0.75
Ext 0.40 a5 0.78
Pro 20.22 20.33 a5 0.81
Self-report
SDQ
Int 0.53*** 20.02 20.10 a5 0.80
Ext 0.06 0.53*** 20.10 0.27 a5 0.69
Pro 20.02 20.10 0.47*** 20.19 20.23 a5 0.73
MTMM5multi-trait multimethod, Int5 internalizing, Ext5 externalizing, Pro5 prosocial. n 5126 parents; n 5 98 adolescents/adults with ASD;
n 5 79 for parent-self-report comparison. Values are Spearman’s correlation coefficients, except values in the diagonals which are Cronbach’s alphas.
Cross-method correlations of same traits are presented in bold.
***P< 0.001.
INSAR J. Findon et al./Screening in adults with ASD using the SDQ 1359
In contrast to the excellent validity shown by the
parent-report SDQ, self-report SDQ produced a less spe-
cific pattern of correlations with measures of disorders;
emotional and hyperactivity subscales identified fewer
cases (55–60%); and there were more false negatives.
Some adults with ASD might under-report these diffi-
culties or rate them in atypical ways, for example rating
anxiety symptoms under hyperactivity items (e.g., “I
am easily distracted”). Given this non-specificity, if
only self-report SDQ is available then high scores in any
subscale should be taken to indicate the possibility of
co-occurring disorder and further assessment planned
accordingly. Ideally, parent-report (or other informant)
should be sought; in practice, this might mean that the
SDQ has greater utility in adolescent or young adult
populations, who are more likely to be accompanied to
appointments by their parents.
As well as testing the validity of parent- and self-
report SDQ, we tested multi-rater predictive algorithms
that incorporate information from the SDQ impact sup-
plement. This did not markedly improve detection of
comorbidities over parent-report SDQ. This suggests
that in adolescents and adults with ASD, there is little
justification for combining parent- and self-report SDQ
and impact scores using a statistical package. In prac-
tice, it may be sufficient, and indeed easier, to use a
paper version of the parent-report SDQ and the pub-
lished subscale bands.
Having explored the external validity of the SDQ in
this population, we set out to test its construct validity
in measuring hyperactivity, emotional, behavioral and
peer problems, and prosocial behavior using multitrait–
multimethod (MTMM) analysis of parent- and self-
report SDQ. The convergent validity coefficients were
higher than those previously reported in a non-ASD
sample [Goodman et al., 2010]. We generally found
good discriminant validity between the subscales, pro-
viding some evidence that the subscales identify dis-
tinct areas of psychopathology in adolescents and
adults with ASD. Despite this, there was some evidence
of poor discriminant validity between the peer prob-
lems subscale and the emotional symptoms subscale,
where convergent and divergent correlations did not
differ significantly. However, the convergent correla-
tions were around twice the magnitude of the divergent
correlations and this difference was close to significance
(P<0.10). Furthermore, within each rater emotional
and peer problems subscales were highly correlated,
suggesting that these difficulties may be closely linked
in individuals with ASD (e.g., anxiety may be linked to
social situations and peer relationships). There was also
evidence for poor discrimination between parent-
reported behavior problems and self-reported emotional
problems. It is possible that this shows that some prob-
lem behavior(s) identified by parents (e.g., temper tan-
trums) are an indicator of emotional difficulties (e.g.,
fears) but are not clearly articulated as such by the indi-
vidual with ASD. Finally, there was partial evidence for
poor discrimination between parent-reported hyperac-
tivity and self-reported behavior problems. This has
been found in other samples [Goodman et al., 2010]
and it may be difficult to separate these two aspects of
externalizing behavior using a brief questionnaire mea-
sure. The low statistical power achieved in this analysis
may have, in part, contributed to the apparent poor dis-
crimination between some subscales. The three factor
model – internalizing, externalizing, and prosocial
behavior subscales – showed much better discriminant
validity, indicating that the SDQ can clearly differenti-
ate between internalizing and externalizing problems in
adolescents and adults with ASD.
Strengths and Limitations
The promising results of this first attempt to validate
the SDQ in adolescents and adults with ASD should be
interpreted in the context of the strengths and limita-
tions inherent in the study, including the nature of the
sample, the data collection strategy, and the measures
used. The sample included a large group of adolescents
and adults who had both a clinical diagnosis of ASD
and assessment with ‘gold-standard’ diagnostic tools
(ADI-R and/or ADOS-G). However, our sample primarily
consisted of high-functioning individuals, which is not
representative of ASD as a whole. For example, 8% of
our sample was diagnosed with an intellectual disability
in comparison to an estimated prevalence in children
and adolescents of around 40% [Idring et al., 2012;
Investigators AaDDMNS, 2012; Pedersen et al., 2012;
Saemundsen, Magnusson, Georgsdottir, Egilsson, &
Rafnsson, 2013]. Therefore, we can only generalize our
findings to higher functioning individuals with ASD.
The SDQ was administered to parents and their off-
spring with ASD at two time-points. Administering to
parents and individuals with ASD allowed us to estab-
lish inter-rater reliability and gain important informa-
tion about construct validity. Additionally, re-
administering the SDQ to both groups allowed us to
explore test-retest stability for both parent- and self-
report SDQ. Test-retest reliability is usually measured by
re-administering the assessment after a brief interval of
approximately 1–4 weeks. However, in the current
study retest was not carried out until on average 11
months after initial assessment. Therefore, changes in
the score may reflect genuine alterations in the
respondent’s psychological adjustment as well as poor
measurement reliability. Nevertheless, we report a satis-
factory lower bound for true test-retest reliability which
was similar across raters and comparable to a non-ASD
population tested after a shorter interval.
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We also compared the SDQ to a range of measures of
psychopathology and using a variety of methods,
including some of the most widely used screening tools
for psychopathology in the UK (BAARS-IV, HADS, and
the OCI-R) and clinical diagnoses assigned by practicing
clinicians. The pattern of converging results makes it
likely that the associations with the SDQ are robust and
not entirely attributable to common method variance
(i.e., SDQ and other questionnaires being completed by
the same rater). For example, parent-report SDQ emo-
tional problems correlated with the OCI-R, which is a
self-report questionnaire, and with diagnosis of OCD
assigned by clinician.
However, there were limitations to the data. While the
sample consisted of adolescents and adults with ASD
who were largely in contact with services because of
ASD-related difficulties, they were recruited from a vari-
ety of sources, making it harder to generalize results to
one clear population. Future studies should recruit sam-
ples from single sources (e.g., specific healthcare settings)
to determine the utility of the SDQ in each setting. It
was also clear from clinical notes that despite having evi-
dence of comorbid disorder some individuals had not
received further assessment. Nonetheless, we attempted
to capture the possibility of disorder in these cases, while
not artificially inflating rates of disorder, by rating them
as possible rather than definite disorder. Furthermore, we
were not able to employ a ‘gold-standard’ diagnostic
approach to measuring co-occurring disorders and the
other measures to which we compared the SDQ (DAWBA
and screening questionnaires) have not been validated in
adults with ASD. Indeed, the lack of validated screening
tools is what motivated this pilot study. We therefore
compared the SDQ to other indicators of high risk of co-
occurring disorders, rather than definitive diagnoses. The
converging evidence across multiple methods of assess-
ment lends support to the validity of the SDQ; however,
further validation is required using definitive diagnoses.
In some individuals information about the time gap
between assessment with the SDQ and with other meas-
ures (screening questionnaires, clinical assessment) was
not available; consequently, disagreement between the
SDQ and other measures may have reflected genuine
change in mental state rather than poor performance of
the SDQ. This would have acted to decrease the strength
of association between the SDQ and other measures;
despite this, a consistent pattern of significant associa-
tions emerged across measures. Finally, whilst disruptive
behavior may be a problem in adolescents and adults
with ASD, we did not have sufficient clinical data to vali-
date the conduct problems subscale.
In summary, this first attempt to validate the SDQ sug-
gests that it may be a reliable and valid way to screen for
co-morbid emotional disorders and ADHD in adolescents
and adults in clinical services or seeking help for ASD-
related difficulties. Given the high prevalence of co-
occurring mental health conditions, impact on individu-
als with ASD, and burden to their families, it is
extremely important to detect the emergence of these
disorders during adolescence and adulthood. The SDQ
shows promise as a tool that could be used to regularly
screen for co-occurring disorders in people with ASD,
helping to reduce the cost to them and their families.
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